Skip to main content
Journal ArticleOPEN ACCESS

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes

Clinical Infectious Diseases (2013) 56(2) 267-270
DOI: 10.1093/cid/cis883
66Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Current Japanese encephalitis vaccines are derived from strains of genotype III, yet heterologous genotypes are emerging in endemic areas. Inactivated vaccines given to European travelers were found to elicit protective levels of neutralizing antibodies against heterologous strains of genotypes I-IV. © 2012 The Author. Published by Oxford University Press on behalf of the Infectious Diseases Society of America.

Author supplied keywords

Cite

CITATION STYLE

APA

Erra, E. O., Askling, H. H., Yoksan, S., Rombo, L., Riutta, J., Vene, S., … Kantele, A. (2013). Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes. Clinical Infectious Diseases, 56(2), 267–270. https://doi.org/10.1093/cid/cis883

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free